Literature DB >> 31282018

Modeling the regulation of p53 activation by HIF-1 upon hypoxia.

Ping Wang1, Di Guan1, Xiao-Peng Zhang2,3, Feng Liu1,3, Wei Wang1,3.   

Abstract

As a famous tumor suppressor, p53 is also activated under hypoxic conditions. Hypoxia-inducuble factor 1, HIF-1, is involved in the activation of p53 upon hypoxia. However, how p53 is modulated by the HIF-1 pathway to decide cell fate is less understood. In this work, we developed a network model including p53 and HIF-1 pathways to clarify the mechanism of cell fate decision in response to hypoxia. We found that HIF-1α and p53 are activated under different conditions. Under moderate hypoxia, HIF-1α is activated to induce glycolysis or angiogenesis, and promotes partial accumulation of p53 by inducing PNUTS. Under severe hypoxia, p53 rises to high levels due to ATR-dependent stabilization and promotes Mdm2-dependent HIF-1α degradation. As a result, fully activated p53 triggers apoptosis. Of note, competition for p300 between HIF-1α and p53 plays a key role in regulating their transcriptional activities. This work may advance the understanding of the mechanism for p53 regulation by HIF-1 in the hypoxic response.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  HIF-1α; cell fate decision; hypoxia; network model; p53 activation

Year:  2019        PMID: 31282018     DOI: 10.1002/1873-3468.13525

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

Review 2.  Systems biology of angiogenesis signaling: Computational models and omics.

Authors:  Yu Zhang; Hanwen Wang; Rebeca Hannah M Oliveira; Chen Zhao; Aleksander S Popel
Journal:  WIREs Mech Dis       Date:  2021-12-30

3.  A dual role of HIF1α in regulating osteogenesis-angiogenesis coupling.

Authors:  Jingjing Shao; Shibo Liu; Min Zhang; Shujiang Chen; Shuaiqi Gan; Chenfeng Chen; Wenchuan Chen; Lei Li; Zhimin Zhu
Journal:  Stem Cell Res Ther       Date:  2022-02-05       Impact factor: 6.832

Review 4.  p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance.

Authors:  Leonel Cardozo de Menezes E Souza; Anderson Faletti; Carla Pires Veríssimo; Mariana Paranhos Stelling; Helena Lobo Borges
Journal:  Membranes (Basel)       Date:  2022-02-09

5.  Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells.

Authors:  Immacolata Maietta; Amparo Martínez-Pérez; Rosana Álvarez; Ángel R De Lera; África González-Fernández; Rosana Simón-Vázquez
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-02

Review 6.  MicroRNAs-mediated regulation of glucose transporter (GLUT) expression in glioblastoma.

Authors:  Ozal Beylerli; Galina Sufianova; Alina Shumadalova; Daming Zhang; Ilgiz Gareev
Journal:  Noncoding RNA Res       Date:  2022-09-06

7.  Cationic amino acid transporter-1 (CAT-1) promotes fibroblast-like synoviocyte proliferation and cytokine secretion by taking up L-arginine in rheumatoid arthritis.

Authors:  Ying Lu; Chongbo Hao; Shanshan Yu; Zuan Ma; Xuelian Fu; Mingqing Qin; Menglei Ding; Zengguang Xu; Lieying Fan
Journal:  Arthritis Res Ther       Date:  2022-10-17       Impact factor: 5.606

8.  Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.

Authors:  Kai Liu; Minying Zheng; Qi Zhao; Kexin Zhang; Zugui Li; Fangmei Fu; Hao Zhang; Jiaxing Du; Yuwei Li; Shiwu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-05-11

Review 9.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

Review 10.  Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation.

Authors:  Stefan Werner; Gunhild von Amsberg; Lina Merkens; Verena Sailer; Davor Lessel; Ella Janzen; Sarah Greimeier; Jutta Kirfel; Sven Perner; Klaus Pantel
Journal:  J Exp Clin Cancer Res       Date:  2022-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.